脂质过氧化
椎间盘
变性(医学)
化学
氧化应激
细胞生物学
铁转运蛋白
退行性椎间盘病
医学
HMGB1
串扰
GPX4
去铁胺
神经科学
背痛
生物化学
热休克蛋白
下调和上调
信号转导
纤维化
退行性疾病
抗氧化剂
病理
基因亚型
炎症
程序性细胞死亡
腰痛
超氧化物歧化酶
作者
Qiyun Shi,Xiaotong Xu,Shen Zhai,Jitian Li,Yongwei Song
标识
DOI:10.3389/fcell.2026.1938559
摘要
The weak correlation between radiographic disc degeneration and pain intensity remains unresolved in intervertebral disc degeneration (IVDD). This Review proposes that iron-dependent lipid peroxidation and ferroptosis-associated redox signalling constitute an underrecognised link between degenerative stress and a pro-nociceptive disc microenvironment. Two linked frameworks are developed. The pro-ferroptotic niche integrates four disc-specific mechanisms: Piezo1-mediated iron influx, ferroportin suppression, ferritinophagy mediated by the cargo receptor NCOA4, and glycolysis-derived lactate upregulating the PUFA-activating enzyme ACSL4. ALOX15-coupled lipid peroxidation rests mainly on cross-disease inference. The ferroptotic pain hub proposes that resulting damage-associated signals, including the alarmin HMGB1 and 4-hydroxynonenal, may converge on NF- κ B-dependent induction of NGF, BDNF, and IL-6. Relevant receptor-level signalling is supported in disc cells, whereas the ferroptosis-specific coupling remains untested. Intervention is organised into four tiers: iron handling, antioxidant-reserve restoration, lipid-peroxidation blockade, and damage-signal–NF- κ B interruption. Deferoxamine and N-acetylcysteine are discussed as an illustrative, unvalidated multi-tier combination, with translation constrained by the need for disc-adapted delivery, intradiscal pharmacokinetic/pharmacodynamic characterisation, local safety assessment, and pain-endpoint validation. Disc-specific evidence, cross-disease inference, mechanistic inference, and hypothesis-level prediction are distinguished throughout, with falsifiable tests defined. The aim is not to present ferroptosis as a proven cause of discogenic pain, but to offer a testable framework for mechanism-based stratification of painful IVDD.
科研通智能强力驱动
Strongly Powered by AbleSci AI